With soaring rates of cardiovascular disease and type 2 diabetes around the world, there is a need to better inform both physicians and the public about how these diseases can effectively be prevented. Although progress has been made with regard to therapeutic options for traditional risk factors such as smoking, hypertension, LDL-chlolesterol, elevated triglycerides and blood sugar levels, there is room for progress with regard to newer risk factors such as abdominal obesity and its associated metabolic complications such as insulin resistance. www.cardiometabolic-risk.org